Story

Aehr Test Stock Surges After Smashing Earnings Estimates, Issues Explosive AI-Driven Forecast

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20262 min read
Aehr Test Stock Surges After Smashing Earnings Estimates, Issues Explosive AI-Driven Forecast

Summary

Shares of Aehr Test Systems skyrocketed after the semiconductor equipment maker posted a significant earnings beat and issued a fiscal 2027 revenue forecast that far surpassed analyst expectations, fueled by a successful pivot to AI-related markets.

Text size
Background

Aehr Test Systems (AEHR) shares surged more than 29% in pre-market trading after the company reported fiscal fourth-quarter results and forward-looking guidance that dramatically exceeded Wall Street expectations. The semiconductor equipment firm's performance was driven by record bookings and a strategic shift toward the artificial intelligence and silicon photonics markets.

Blowout Quarter and Record Bookings

The company announced its financial results after Tuesday's market close, revealing a significant outperformance on key metrics. The report highlighted a fundamental strengthening in its business operations and demand.

  • Adjusted Earnings Per Share: $0.11, compared to consensus analyst estimates of a $0.01 loss.
  • Revenue: $18.8 million, beating the $17.92 million forecast and representing a 33% increase from the same quarter a year earlier.
  • Quarterly Bookings: Reached a record $60.7 million, a more than fivefold increase from $11.1 million in the prior-year period.
  • Effective Backlog: Grew to a record $100.6 million.

AI Pivot Fuels Staggering Guidance

Sample IUX Markets – In-articleAd

Management's outlook for fiscal 2027 reset growth expectations for the company. Aehr Test projected revenue to be between $130 million and $150 million, representing growth of 160% to 200%. This forecast is substantially higher than the roughly $85 million consensus estimate among analysts. The company also guided for non-GAAP pretax margins of 18–22%.

CEO Gayn Erickson attributed the robust outlook to a successful business transformation. "Just two years ago, over 95% of our business was tied to silicon carbide for electric vehicles, whereas today, almost 95% of our fiscal year 2026 revenue came from markets not electric vehicle silicon carbide," Erickson stated on the earnings call, pointing to strong demand from AI processors and silicon photonics.

Market Context

The stock's dramatic move lifted it from a 52-week low of $14.01 toward the $93–$95 range in pre-market activity. While the broader semiconductor sector saw a lift from positive inflation data and a bullish forecast from equipment giant ASML, Aehr's massive gains were overwhelmingly driven by its own blockbuster report and transformative guidance.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST